4-fluorobenzyltrozamicol has been researched along with Glucose Intolerance in 1 studies
*Glucose Intolerance: A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calles-Escandon, J; Clark, PB; Gage, HD; Garg, P; Garg, S; Kavanagh, K; Morton, K; Wagner, JD | 1 |
1 other study(ies) available for 4-fluorobenzyltrozamicol and Glucose Intolerance
| Article | Year |
|---|---|
Enhanced cholinergic response in pancreata of nonhuman primates with impaired glucose tolerance shown on [18F]fluorobenzyltrozamicol positron emission tomography.
Topics: Animals; Blood Glucose; Chlorocebus aethiops; Female; Fluorine Radioisotopes; Fluorobenzenes; Glucose Intolerance; Insulin; Piperidines; Positron-Emission Tomography; Primates; Reference Values; Triglycerides | 2009 |